Arcturus Therapeutics Holdings, Inc. (ARCT)

10.35 -0.92 (-8.16%) USD  |  NASDAQ  |  Oct 16, 12:46
More

Arcturus Therapeutics Holdings SG&A Expense (TTM) : 44.88M for June 30, 2026

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 44.88M
March 31, 2026 44.23M
December 31, 2025 46.08M
September 30, 2025 44.43M
June 30, 2025 47.31M
March 31, 2025 49.29M
December 31, 2024 52.82M
September 30, 2024 52.95M
June 30, 2024 53.05M
March 31, 2024 53.96M
December 31, 2023 52.87M
September 30, 2023 52.22M
June 30, 2023 51.34M
March 31, 2023 49.10M
December 31, 2022 46.07M
September 30, 2022 45.02M
June 30, 2022 43.39M
March 31, 2022 42.44M
December 31, 2021 41.45M
September 30, 2021 39.68M
June 30, 2021 34.39M
March 31, 2021 28.77M
December 31, 2020 23.22M
September 30, 2020 15.97M
June 30, 2020 14.28M
Date Value
March 31, 2020 13.32M
December 31, 2019 12.66M
September 30, 2019 14.31M
June 30, 2019 14.24M
March 31, 2019 19.02M
December 31, 2018 20.58M
September 30, 2018 19.80M
June 30, 2018 17.82M
March 31, 2018 11.97M
December 31, 2017 8.441M
September 30, 2017 7.432M
June 30, 2017 6.81M
March 31, 2017 5.832M
December 31, 2016 5.717M
September 30, 2016 5.396M
June 30, 2016 5.361M
March 31, 2016 5.161M
December 31, 2015 4.992M
September 30, 2015 5.103M
June 30, 2015 5.193M
March 31, 2015 5.339M
December 31, 2014 5.839M
September 30, 2014 5.444M
June 30, 2014 5.247M
March 31, 2014 4.774M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 620.29M
Emergent BioSolutions, Inc. 181.20M
Exelixis, Inc. 533.92M
Ionis Pharmaceuticals, Inc. 527.56M
United Therapeutics Corp. 644.60M